
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-c... Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0.082 | 0.082 | 0.082 | 0 | 0 | CS |
4 | -0.0269 | -24.7015610652 | 0.1089 | 0.1099 | 0.077 | 799913 | 0.0921492 | CS |
12 | -0.323 | -79.7530864198 | 0.405 | 0.42 | 0.077 | 4902556 | 0.16224926 | CS |
26 | -0.918 | -91.8 | 1 | 1.0155 | 0.077 | 2354720 | 0.17259544 | CS |
52 | -3.248 | -97.5375375375 | 3.33 | 3.45 | 0.077 | 1215567 | 0.22056378 | CS |
156 | -11.678 | -99.3027210884 | 11.76 | 16.5 | 0.077 | 585254 | 2.56440573 | CS |
260 | -62.018 | -99.8679549114 | 62.1 | 158.1 | 0.077 | 650037 | 27.35293897 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions